These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22145189)

  • 41. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clarification of registration requirements for individual practitioners. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2006 Dec; 71(231):69478-80. PubMed ID: 17171847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Interim rule with request for comments.
    Drug Enforcement Administration (DEA), U.S. Department of Justice
    Fed Regist; 2007 Apr; 72(77):20039-47. PubMed ID: 17520757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Mar; 75(53):13225-32. PubMed ID: 20383919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Canadian federal methamphetamine precursor and essential chemical regulations on methamphetamine-related acute-care hospital admissions.
    Callaghan RC; Cunningham JK; Victor JC; Liu LM
    Drug Alcohol Depend; 2009 Dec; 105(3):185-93. PubMed ID: 19699042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of the origin of ephedrine and methamphetamine by stable isotope ratio mass spectrometry: a Japanese experience.
    Makino Y; Urano Y; Nagano T
    Bull Narc; 2005; 57(1-2):63-78. PubMed ID: 21338016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigational new drug applications; clinical holds; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Dec; 63(239):68710-2. PubMed ID: 10187560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures.
    Cunningham JK; Callaghan RC; Tong D; Liu LM; Li HY; Lattyak WJ
    Drug Alcohol Depend; 2012 Nov; 126(1-2):55-64. PubMed ID: 22592141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Child support enforcement program; state plan requirements, standards for program operations, and federal financial participation--Office of Child Support Enforcement, HHS. Notice of proposed rulemaking.
    Fed Regist; 1998 Jan; 63(2):187-93. PubMed ID: 10176837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recordkeeping and reporting under Title VII and the ADA--EEOC. Final rule.
    Fed Regist; 1991 Jul; 56(144):35753-6. PubMed ID: 10170777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mexico's methamphetamine precursor chemical interventions: impacts on drug treatment admissions.
    Cunningham JK; Bojorquez I; Campollo O; Liu LM; Maxwell JC
    Addiction; 2010 Nov; 105(11):1973-83. PubMed ID: 20707864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Schedules of controlled substances; table of excluded nonnarcotic products: nasal decongestant inhalers manufactured by Classic Pharmaceuticals, LLC. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2010 Mar; 75(55):13678-9. PubMed ID: 20383920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occupational injury and illness recording and reporting requirements. Occupational Safety and Health Administration (OSHA), U.S. Department of Labor. Final rule.
    Fed Regist; 2001 Jan; 66(13):5916-6135. PubMed ID: 11503778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Aug; 63(152):42300-4. PubMed ID: 10181727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting.
    Cunningham JK; Liu LM; Muramoto M
    Addiction; 2008 Jul; 103(7):1174-86. PubMed ID: 18422822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medicaid program; time limitation on record keeping requirements under the drug rebate program. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2004 Jan; 69(3):508-14. PubMed ID: 14968795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Schedules of controlled substances: extension of temporary placement of methylone into schedule I of the Controlled Substances Act. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2012 Oct; 77(202):64032-3. PubMed ID: 23077760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Some cold medicines move behind counter.
    Bren L
    FDA Consum; 2006; 40(4):18-9. PubMed ID: 17243283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medical devices; reports of corrections and removals--FDA. Direct final rule.
    Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substance Abuse and Mental Health Services Administration; requirements applicable to protection and advocacy of individuals with mental illness; final rule--Center for Mental Health Services, SAMHSA. Final rule.
    Fed Regist; 1997 Oct; 62(199):53548-71. PubMed ID: 10177296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.